ALLMedicine™ Thrush Center
Research & Reviews 151 results
http://emedicine.medscape.com/article/270872-workup
May 2nd, 2022 - Practice Essentials Vulvovaginitis is a general term referring to many types of vaginal infection, although this article focuses on the following disorders, which affect the vulvar region: Vulvovaginal candidiasis Atrophic vaginitis Vulvar vestibu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041809
PLoS Pathogens; Lemberg C, Martinez de San Vicente K et. al.
Apr 12th, 2022 - As part of the human microbiota, the fungus Candida albicans colonizes the oral cavity and other mucosal surfaces of the human body. Commensalism is tightly controlled by complex interactions of the fungus and the host to preclude fungal eliminati...
https://doi.org/10.1645/21-93
The Journal of Parasitology; Sasaki M, Iwaki T et. al.
Mar 11th, 2022 - Michajlovia turdi (Yamaguti, 1939) (Digenea: Brachylaimoidea) has been found from the Japanese thrush, Turdus cardis Temminck, 1831, in Hokkaido, the northernmost island of Japan. This is a rediscovery of M. turdi in Japan after approximately 80 y...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860281
BMC Pediatrics; Masoza TS, Rwezaula R et. al.
Feb 23rd, 2022 - Provider Initiated Testing and Counseling (PITC) among hospitalized children have shown to increase the probability of identifying HIV-infected children and hence be able to link them to HIV care. We aimed at determining the prevalence, clinical c...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744138
The Cochrane Database of Systematic Reviews; Cooke G, Watson C et. al.
Jan 11th, 2022 - Recurrent vulvovaginal candidiasis (RVVC) affects up to 5% of women. No comprehensive systematic review of treatments for RVVC has been published. The primary objective was to assess the effectiveness and safety of pharmacological and non-pharmaco...
Drugs 19 results see all →
Clinicaltrials.gov 8 results
https://clinicaltrials.gov/ct2/show/NCT00000951
Oct 29th, 2021 - This study will evaluate two different management strategies for patients with advanced HIV infection who are at risk for recurrent and fluconazole-refractory oropharyngeal candidiasis. The treatment duration will be at least 24 months in order to...
https://clinicaltrials.gov/ct2/show/NCT04776538
Mar 1st, 2021 - Background: Xerostomia is the diagnosis of the subjective feeling of dry mouth. Xerostomia can coexist with or exist without a reduced production of saliva, although xerostomia is first perceived when unstimulated whole saliva flow rate is reduced...
https://clinicaltrials.gov/ct2/show/NCT04575831
Dec 3rd, 2020 - Lung cancer is the most commonly diagnosed cancer in Canada, and is the leading cause of death from cancer.1 Despite this, long-term survival rates for lung cancer are improving, owing largely to recent advances in treatment. The progression of sy...
https://clinicaltrials.gov/ct2/show/NCT03407157
Jan 22nd, 2020 - Background: Group B streptococcus (GBS) infection of the newborn is a leading cause of neonatal morbidity and mortality in North America. Up to 30% of pregnant women are colonized with GBS. Half of the babies born to colonized mothers will become ...
https://clinicaltrials.gov/ct2/show/NCT03354650
Dec 5th, 2017 - More than 40% of under-five deaths globally occur in the neonatal period, resulting in 3.1 million newborn death each year. The majority of these deaths usually occur in low income countries . On the other hand, the survivors of neonatal sepsis ar...
News 38 results
https://www.medscape.com/viewarticle/970360
Mar 16th, 2022 - The US Food and Drug Administration (FDA) approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol for the treatment of asthma in patients 6 years of age and older and for the maintenance treatment ...
https://www.medscape.com/viewarticle/746588
Mar 15th, 2022 - Editorial Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills u...
https://www.medscape.com/viewarticle/949914
Apr 24th, 2021 - Secukinumab is the latest adult plaque psoriasis treatment to be bested by a newcomer, the interleukin 17A and 17F blocker bimekizumab. Rates of complete clearance were substantially higher with bimekizumab in a phase 3 trial with 743 patients wit...
https://www.medpagetoday.com/dermatology/psoriasis/91067
Feb 5th, 2021 - The monoclonal antibody bimekizumab was more effective than ustekinumab (Stelara) or placebo for moderate-to-severe plaque psoriasis in a phase III trial, investigators reported. At week 16, a 90% improvement on the Psoriasis Area and Severity Ind...
https://reference.medscape.com/viewarticle/928542_4
Apr 17th, 2020 - Fluconazole or oral nystatin suspension is the treatment of choice for thrush, and several other antifungal agents are also effective. For older children and adults, antifungal medications should be swished around in the oral cavity and swallowed....